Skylar Saville
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,402 | 255 | 99.3% |
| Education | $25.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $913.97 | 89 | $0 (2024) |
| Novo Nordisk Inc | $491.00 | 50 | $0 (2024) |
| Lilly USA, LLC | $350.08 | 14 | $0 (2023) |
| GlaxoSmithKline, LLC. | $192.31 | 16 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $185.91 | 10 | $0 (2024) |
| Radius Health, Inc. | $164.03 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $142.08 | 10 | $0 (2023) |
| Amarin Pharma Inc. | $123.53 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $100.12 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.31 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $721.28 | 52 | Novo Nordisk Inc ($166.32) |
| 2023 | $997.05 | 85 | AbbVie Inc. ($244.10) |
| 2022 | $1,460 | 105 | ABBVIE INC. ($523.09) |
| 2021 | $212.29 | 12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.06) |
| 2019 | $16.91 | 1 | Gilead Sciences, Inc. ($16.91) |
| 2018 | $19.12 | 1 | GlaxoSmithKline, LLC. ($19.12) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Obesity | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Diabetes Care | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,086 | 1,613 | $96,177 | $44,992 |
| 2022 | 14 | 556 | 701 | $51,766 | $24,133 |
| 2021 | 9 | 291 | 316 | $43,559 | $16,264 |
| 2020 | 6 | 127 | 162 | $29,580 | $8,456 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 268 | $41,272 | $21,129 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $10,350 | $4,393 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 49 | $5,320 | $2,984 | 56.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $3,780 | $2,506 | 66.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 113 | 223 | $2,230 | $1,873 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 99 | 151 | $6,040 | $1,563 | 25.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 88 | 105 | $4,725 | $1,378 | 29.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 57 | 80 | $3,360 | $1,317 | 39.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 105 | 153 | $3,213 | $1,164 | 36.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $1,092 | $1,061 | 97.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 26 | 37 | $1,554 | $881.71 | 56.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 54 | 78 | $1,638 | $742.56 | 45.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 53 | 68 | $2,380 | $601.12 | 25.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 29 | 38 | $1,140 | $561.64 | 49.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 16 | 17 | $850.00 | $493.17 | 58.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $612.00 | $484.50 | 79.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 32 | $1,152 | $309.90 | 26.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 22 | 22 | $990.00 | $260.80 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 32 | $1,600 | $231.66 | 14.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 15 | 17 | $510.00 | $227.12 | 44.5% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 15 | 17 | $510.00 | $212.50 | 41.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 18 | 25 | $750.00 | $207.25 | 27.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 28 | 31 | $310.00 | $189.41 | 61.1% |
| 83540 | Iron level | Office | 2023 | 15 | 17 | $357.00 | $107.78 | 30.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 23 | 27 | $297.00 | $80.98 | 27.3% |
About Skylar Saville
Skylar Saville is a Student in an Organized Health Care Education/Training Program healthcare provider based in Daphne, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2017. The National Provider Identifier (NPI) number assigned to this provider is 1003349275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Skylar Saville has received a total of $3,427 in payments from pharmaceutical and medical device companies, with $721.28 received in 2024. These payments were reported across 256 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,402).
As a Medicare-enrolled provider, Saville has provided services to 2,060 Medicare beneficiaries, totaling 2,792 services with total Medicare billing of $93,846. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Daphne, AL
- Active Since 04/05/2017
- Last Updated 10/05/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1003349275
Products in Payments
- QULIPTA (Drug) $388.60
- VRAYLAR (Drug) $284.44
- Ozempic (Drug) $250.49
- UBRELVY (Drug) $200.09
- Kerendia (Drug) $185.91
- TALTZ (Drug) $184.69
- Rybelsus (Drug) $150.60
- MOUNJARO (Drug) $125.00
- TRELEGY ELLIPTA (Drug) $124.95
- Vascepa (Drug) $123.53
- Tymlos (Drug) $111.26
- XIFAXAN (Drug) $91.31
- TOUJEO (Biological) $87.49
- Wegovy (Drug) $74.83
- BELSOMRA (Drug) $57.49
- Tymlos (Biological) $52.77
- FARXIGA (Drug) $48.95
- UNITHROID (Drug) $48.28
- Auvelity (Drug) $37.52
- BREZTRI (Drug) $37.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Daphne
Dr. Charles Gordon, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $207,406
Elizabeth Wood, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $12,402
Samantha Lee, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,144
Kinjal Ghelani, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $590.39
Mr. Jacob Swearingen, Dnp, Crna, Bsn, Rn, DNP, CRNA, BSN, RN
Student in an Organized Health Care Education/Training Program — Payments: $34.43
Sheena Hayes, Pharmd, PHARMD
Student in an Organized Health Care Education/Training Program